The main difference is receptor activity
Vitiligo, characterized by the loss of melanocytes and resulting white macules, lacks a definitive cure
GLP-1 agonists are medications that mimic the effect of this hormone and, on average, lower hemoglobin A1C by 0.8% to 1.5%
Unfortunately, while GLP-1s have been proven to work, there has been a rise in popularity of other peptides that come with a lot more risk
demonstrated that the GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant Apoe/Irs2+/ mice by promoting macrophage polarization towards an anti-inflammatory M2 phenotype, which was associated with enhanced plaque stability (i.e., thicker fibrous caps, fewer necrotic cores, and decreased inflammatory infiltrates)
Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men